News

Pfizer Boosts 2025 Adjusted EPS Outlook Following Quarterly Gains
Pfizer boosted its profit outlook for the year following gains to its top- and bottom-line in its latest quarter.
Pfizer raises annual profit forecast after upbeat second quarter
U.S. drugmaker Pfizer on Tuesday raised its full-year profit forecast on strong demand for its heart disease drug, Vyndaqel, ...
Pfizer beats in Q2 earnings, reaffirms 2025 outlook
Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...
Pfizer (NYSE:PFE) Reports Upbeat Q2
Global pharmaceutical company Pfizer (NYSE:PFE) announced better-than-expected revenue in Q2 CY2025, with sales up 10.3% year ...
The Peninsula Qatar36m
Pfizer profits boosted by Covid-19 products, lower expenses
Pfizer reported a jump in second quarter profits Tuesday behind higher sales of Covid 19 products and some other ...
Pfizer rises as Q2 beat leads to guidance raise
Pfizer (NYSE:PFE) stock gains as the company surpasses Q2 2025 expectations with $14.7B revenue and raises its full-year ...
Pfizer boosts 2025 profit estimate in a sign of ‘confidence’
The $3.00-a-share midpoint of its new range would put it just below the FactSet consensus estimate of $3.02 a share for Pfizer’s adjusted 2025 earnings.
Pfizer CEO attending $25 million fundraiser at Trump's golf club after president demands drug price cuts, sources say
Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...
The 3 Things That Matter for Pfizer Now
Pfizer's oncology pipeline looks promising. The company's newer approvals could make significant progress. And its efforts to ...
Fierce Biotech40m
Pfizer's embattled obesity program loses another GLP-1 drug
Pfizer has abanonded yet another GLP-1 drug from its shrinking obesity pipeline, as well as dumping a Clostridium difficile ...